Use este identificador para citar o ir al link de este elemento:
http://hdl.handle.net/1843/60510| Tipo: | Artigo de Periódico |
| Título: | Paraprobiotics and Postbiotics of Lactobacillus delbrueckii CIDCA 133 Mitigate 5-FU-Induced Intestinal Inflammation |
| Autor(es): | Viviane Lima Batista Ênio Ferreira Juliana Guimarães Laguna Luiz Carlos Júnior Alcântara Vasco Ariston de Carvalho Azevedo Luís Cláudio Lima de Jesus Laísa Macedo Tavares Fernanda Alvarenga Lima Barroso Lucas Jorge da Silva Fernandes Andria Dos Santos Freitas Monique Ferrary Américo Mariana Martins Drumond Pamela Mancha-agresti |
| Resumen: | Intestinal mucositis is a commonly reported side effect in oncology practice. Probiotics are considered an excellent alternative therapeutic approach to this debilitating condition; however, there are safety questions regarding the viable consumption of probiotics in clinical practice due to the risks of systemic infections, especially in immune-compromised patients. The use of heat-killed or cell-free supernatants derived from probiotic strains has been evaluated to minimize these adverse effects. Thus, this work evaluated the anti-inflammatory properties of paraprobiotics (heat-killed) and postbiotics (cell-free supernatant) of the probiotic Lactobacillus delbrueckii CIDCA 133 strain in a mouse model of 5-Fluorouracil drug-induced mucositis. Administration of paraprobiotics and postbiotics reduced the neutrophil cells infiltrating into the small intestinal mucosa and ameliorated the intestinal epithelium architecture damaged by 5-FU. These ameliorative effects were associated with a downregulation of inflammatory markers (Tlr2, Nfkb1, Il12, Il17a, Il1b, Tnf), and upregulation of immunoregulatory Il10 cytokine and the epithelial barrier markers Ocln, Cldn1, 2, 5, Hp and Muc2. Thus, heat-killed L. delbrueckii CIDCA 133 and supernatants derived from this strain were shown to be effective in reducing 5-FU-induced inflammatory damage, demonstrating them to be an alternative approach to the problems arising from the use of live beneficial microorganisms in clinical practice. |
| Asunto: | Microbiologia Mucosite Tratamento Farmacológico Intestinos Imunomodulação |
| Idioma: | eng |
| País: | Brasil |
| Editor: | Universidade Federal de Minas Gerais |
| Sigla da Institución: | UFMG |
| Departamento: | ICB - DEPARTAMENTO DE PATOLOGIA ICB - INSTITUTO DE CIÊNCIAS BIOLOGICAS |
| Tipo de acceso: | Acesso Aberto |
| Identificador DOI: | https://doi.org/10.3390/microorganisms10071418 |
| URI: | http://hdl.handle.net/1843/60510 |
| Fecha del documento: | 14-jul-2022 |
| metadata.dc.url.externa: | https://www.mdpi.com/2076-2607/10/7/1418 |
| metadata.dc.relation.ispartof: | Microorganisms |
| Aparece en las colecciones: | Artigo de Periódico |
archivos asociados a este elemento:
| archivo | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Paraprobiotics and Postbiotics of Lactobacillus delbrueckii CIDCA 133 Mitigate 5-FU-Induced Intestinal Inflammation.pdf | 1.46 MB | Adobe PDF | Visualizar/Abrir |
Los elementos en el repositorio están protegidos por copyright, con todos los derechos reservados, salvo cuando es indicado lo contrario.